Rats with Human Mutation of NFU1 Develop Pulmonary Hypertension.
NFU1 is a mitochondrial protein involved in iron-sulfur clusters biosynthesis, and its genetic modification is associated with disorders of mitochondrial energy metabolism. Patients with autosome recessive inheritance of NFU1 mutation G208C have reduced activity of the respiratory chain complex II, lipoic-acid dependent enzymes, and develop pulmonary arterial hypertension (PAH) in ~ 70% of cases. We investigated whether rats with a human mutation in NFU1 are also predisposed to PAH development. A point mutation in rat NFU1G206C (human G208C) was introduced through CRISP/Cas9 genome editing. Hemodynamic data, tissue samples, and fresh mitochondria were collected and analyzed. NFU1G206C rats showed an increased right ventricular (RV) pressure, RV hypertrophy and high levels of pulmonary artery remodeling. Computed tomography and angiography of the pulmonary vasculature indicated severe angioobliterative changes in NFU1G206C rats. Importantly, the penetrance of PAH phenotype was found to be more prevalent in females than in males, replicating the established gender difference within PAH patients. Male and female homozygote rats exhibited a decreased expression and activity of mitochondrial complex II, and markedly decreased pyruvate dehydrogenase activity and lipoate binding. The limited development of PAH in males correlated with the preserved levels of oligomeric NFU1, increased expression of ISCU, an alternative branch of iron-sulfur assembly system, and increased complex IV activity. Thus, the male sex has additional plasticity to overcome the iron-sulfur cluster deficiency. Our work describes a novel, humanized rat model of NFU1 deficiency showed mitochondrial dysfunction similar to patients and developed PAH with the same gender dimorphism.